Literature DB >> 26103606

Ghrelin and atherosclerosis.

Olavi Ukkola1.   

Abstract

PURPOSE OF REVIEW: The increasing prevalence of metabolic syndrome and the consequent cardiovascular diseases has stimulated an active search for novel risk factors. The hormones regulating energy balance are of special interest as potential risk factor indicators of cardiovascular diseases. Ghrelin provides an attractive target for studies of atherosclerosis being a gastric peptide hormone having multiple functions including orexigenic and growth hormone-releasing effects and is also involved in the regulation of cardiovascular and immunomodulatory system. RECENT
FINDINGS: The aim of the present article is to review recent studies on the role of ghrelin in the atherosclerosis. Ghrelin seems to influence known risk factors of atherosclerosis, endothelial dysfunction, inflammation and oxidation. These themes will be covered by the present article and a summary of clinical studies of ghrelin in atherosclerosis will be given.
SUMMARY: Ghrelin plays a beneficial role in multiple processes of atherogenesis and vascular function. However, ghrelin's effects are not as strong as those of traditional known risk factors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26103606     DOI: 10.1097/MOL.0000000000000183

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  3 in total

1.  Peptide hormones and risk for future cardiovascular events among prediabetics: a 20-year follow-up in the OPERA study.

Authors:  Olli-Juhani Galla; Antti Ylitalo; Antti Kiviniemi; Heikki Huikuri; Y Antero Kesäniemi; Olavi Ukkola
Journal:  Ann Med       Date:  2020-03-22       Impact factor: 4.709

Review 2.  Ghrelin, MicroRNAs, and Critical Limb Ischemia: Hungering for a Novel Treatment Option.

Authors:  Joshua P H Neale; James T Pearson; Rajesh Katare; Daryl O Schwenke
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-13       Impact factor: 5.555

Review 3.  Research progress of ghrelin on cardiovascular disease.

Authors:  Ming-Jie Yuan; Wei Li; Peng Zhong
Journal:  Biosci Rep       Date:  2021-01-29       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.